Comparison of Two Treatment Strategies in Hypertensive Patients
NCT00171444 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 4445
Last updated 2011-11-08
Summary
The purpose of the study is to determine whether a specific training of General Practitioners (Family Physicians) regarding the new official guidelines for the treatment of hypertension results in a higher control of high Blood pressure in their patient population.
Conditions
Interventions
- BEHAVIORAL
-
Medical education
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novatis Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-06-30
- Primary Completion
- 2005-05-31
- Completion
- 2005-05-31
More Related Trials
-
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
NCT00280540 ·Status: COMPLETED ·Phase: PHASE4
-
Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
NCT00170989 ·Status: COMPLETED ·Phase: PHASE3
-
Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults
NCT00439738 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age
NCT00171041 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
NCT00698646 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg
NCT00241137 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
NCT00425997 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension
NCT00171028 ·Status: COMPLETED ·Phase: PHASE3
-
The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure
NCT00241098 ·Status: COMPLETED ·Phase: PHASE4
-
VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients
NCT00394823 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension
NCT00523744 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
NCT00171535 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD
NCT01617681 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
NCT00351130 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients.
NCT00171756 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
NCT00241007 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
NCT00304226 ·Status: COMPLETED ·Phase: PHASE4
-
Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension
NCT00931710 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension
NCT00171054 ·Status: COMPLETED ·Phase: PHASE4
-
Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension
NCT01415505 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
NCT01508026 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure
NCT00171106 ·Status: COMPLETED ·Phase: PHASE4
-
Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.
NCT01541189 ·Status: COMPLETED ·Phase: PHASE4
-
Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure
NCT00435162 ·Status: COMPLETED ·Phase: PHASE3
-
To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.
NCT00170924 ·Status: COMPLETED ·Phase: PHASE4